| Literature DB >> 35345347 |
Chukkris Heawchaiyaphum1,2, Tipaya Ekalaksananan1,2, Natcha Patarapadungkit2,3, Patravoot Vatanasapt2,4, Chamsai Pientong1,2.
Abstract
BACKGROUND: Human papillomavirus (HPV) and Epstein-Barr virus (EBV) are associated with head and neck cancer, including tonsil cancer (TC) in the oropharyngeal area. Increasing incidence of HPV and EBV infection in different cancer tissues of oropharynx in both epithelial and lymphoid tissues, have been reported. However, little is known about association of these tumor viruses with TC in the Thai population. Here, we investigated the prevalence of HPV and EBV infection in different histology of TC and their association with TC from Thai patients.Entities:
Keywords: Epstein-Barr Virus; diffuse large B cell lymphoma; human papillomavirus; tonsillar squamous cell carcinoma
Mesh:
Year: 2022 PMID: 35345347 PMCID: PMC9360956 DOI: 10.31557/APJCP.2022.23.3.781
Source DB: PubMed Journal: Asian Pac J Cancer Prev ISSN: 1513-7368
Primer Sequences
| Primer name | Forward (5'-3') | Reward (5'-3') | Reference |
|---|---|---|---|
| GP5+/GP6+ | TTTGTTACTGTGGTAGATACTAC | GAAAAATAAACTGTAAATCATATTC | van den Brule et al., 2002 |
| BALF5 | CGAGTCATCTACGGGGACACGGA | AGCACCCCCACATATCTCTTCTT | Pozo and Tenorio, 1999 |
Demographic Data of Normal Control (NCC) and Tonsil Cancer Patients (TC) with Histological Difference of TSCC and DLBCL
| Demographic | NCCa (n=83) | TSCCb (n=36) | DLBCLc (n=29) |
|---|---|---|---|
| Age range (years) | 24-84 | 27-81 | 7-83 |
| Age (years, mean ± SD) | 61.70 ± 14.15 | 54.03 ± 12.35 | 50.48 ± 18.53 |
| Sex | |||
| Male | 32 (38.55%) | 31 (86.11%) | 15 (51.72%) |
| Female | 51 (64.45%) | 5 (13.19%) | 14 (48.28%) |
| Histology | |||
| Well differentiated | - | 23 (63.89%) | - |
| Moderately differentiated | - | 8 (22.22%) | - |
| Poorly differentiated | - | 4 (11.11%) | - |
| Undifferentiated | - | 1 (2.78%) | - |
Figure 1The Prevalence of HPV, EBV and Co-Occurrence Infection in NCC and TC Samples. Chi-square test was used to compare the prevalence of HPV, EBV and co-occurrence infection in NCC and TC cases (*: p < 0.05; **: p < 0.01; ***: p < 0.001)
Figure 2The Prevalence of HPV, EBV and Their Co-Occurrence in NCC, TSCC and DLBCL. Chi-square test was used to analyze the prevalence of HPV, EBV and their co-occurrence in NCC, TSCC and DLBCL (*: p < 0.05; **: p < 0.01; ***: p < 0.001).
Figure 3Distribution of HPV Genotypes in TSCC and DLBCL Using RLBH Method
Figure 4HPV58 Genome Physical Status in TSCC and DLBCL Using Multiplex qPCR